ATS 2024 Final Program

Click on the session title to view the speakers

SUNDAY • MAY 19

55

P831 Pulmonary Manifestations in Psoriasis: A Single Center Experience P832 Interdisciplinary Collaboration in the Care of Patients With Connective Tissue Disease-related Interstitial Lung Disease: An Interview Study P833 The Safety Profile of Transbronchial Lung Biopsy in Patients With ILD Undergoing Tissue Collection for the Envisia Genomic Classifier P834 Assessment of Clinical Status Post Envisia Genomic Analysis in a Cohort With Parenchymal Infiltrates P835 Adding an Exposure History and BAL Fluid Analysis to an Envisia Genomic Classifier Test Enhances IPF Diagnostic Confidence P836 Clinical Significance of Bronchoalveolar Lymphocytosis and Genomic Classifier in Interstitial Lung Disease P837 Impact of the COVID-19 Pandemic on a Longitudinal Program to Screen for Subclinical Familial Pulmonary Fibrosis P838 Predictors of Pulmonary Hypertension in Patients With Interstitial Lung Disease P839 Assessing the Utility of Serological Markers and Patient Demographics in Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) Diagnosis: A Retrospective Analysis P840 Anti-Mi-2-associated ILD: A Unique Disease or a Mixed Picture? P841 Predictors of Relapse of Aminoacyl tRNA Synthetase Syndrome Associated Interstitial Lung Disease P842 Comparison of Diagnostic Accuracy Between Pre and Post-Transplant ILD Diagnosis in Patients Referred From Sub-specialty ILD Clinics Versus Community P843 Six-minute Walk Test: Clinical Significance in Pulmonary Hypertension in Patients With Idiopathic Pulmonary Fibrosis P844 Breathless Battle: Unmasking Immune Checkpoint-inhibitor Pneumonitis in Cancer Patients - A Case Series P845 Reliability of Inspiratory Crackles in Patients With Pulmonary Fibrosis: A Prospective, Longitudinal Study

P846 Improved Time to Diagnosis for Ultra Rare Lung Diseases in a National Referral Centre P847 The Pattern of Cardiac Lesions’ Onset in Sarcoidosis Patients P848 Impact of Instilled Saline Volume on Adequate Bronchoalveolar Lavage Sample in Interstitial Lung Disease Diagnosis P849 Challenges in Detecting Progressive Pulmonary Fibrosis in Patients With Primary Sjögren’s Syndrome-associated Interstitial Lung Disease P850 A Preliminary Conceptual Model of Cough Symptoms and Impacts in Interstitial Lung Disease P851 Acute Exacerbation of Idiopathic Pulmonary Fibrosis Triggered by COVID-19 Infection: Semi-Quantitative Evaluation With Computed Tomography P852 Multiple Breath Washout (MBW) Testing to Determine Pre-clinical Airway Involvement in Patients With Systemic Sclerosis (SSc) Without Lung Disease as a Risk Factor for Developing Interstitial Lung Disease (ILD) P853 The Impact of CT Manufacturer and Slice Thickness on the Ability of ScreenDx, An AI-based Algorithm, to Detect Incidental Pulmonary Fibrosis P854 Remote Patient Monitoring of ILD Patients Using Oxygen

CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

A47 ILD OUTCOMES 9:15 a.m. - 4:15 p.m.

San Diego Convention Center Area H (Hall H, Ground Level)

Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P856 Patterns and Prevalence of Progressive Pulmonary Fibrosis in Combined Pulmonary Fibrosis and Emphysema

ATS 2024 Conference Program • San Diego, CA